Editorial commentary: Recurrent pericarditis in the era of interleukin-1 inhibition

Trends Cardiovasc Med. 2021 Jul;31(5):275-276. doi: 10.1016/j.tcm.2020.04.010. Epub 2020 May 14.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Interleukin-1*
  • Pericarditis* / diagnosis
  • Pericarditis* / drug therapy
  • Pericarditis* / epidemiology
  • Recurrence

Substances

  • Interleukin-1